Structure

Physi-Chem Properties

Molecular Weight:  460.26
Volume:  510.563
LogP:  7.999
LogD:  4.596
LogS:  -4.531
# Rotatable Bonds:  6
TPSA:  74.6
# H-Bond Aceptor:  4
# H-Bond Donor:  2
# Rings:  3
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.354
Synthetic Accessibility Score:  3.632
Fsp3:  0.4
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.831
MDCK Permeability:  1.3914142982685007e-05
Pgp-inhibitor:  0.038
Pgp-substrate:  0.85
Human Intestinal Absorption (HIA):  0.048
20% Bioavailability (F20%):  0.994
30% Bioavailability (F30%):  0.575

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.008
Plasma Protein Binding (PPB):  85.11798095703125%
Volume Distribution (VD):  1.283
Pgp-substrate:  9.842937469482422%

ADMET: Metabolism

CYP1A2-inhibitor:  0.36
CYP1A2-substrate:  0.247
CYP2C19-inhibitor:  0.864
CYP2C19-substrate:  0.286
CYP2C9-inhibitor:  0.885
CYP2C9-substrate:  0.947
CYP2D6-inhibitor:  0.423
CYP2D6-substrate:  0.203
CYP3A4-inhibitor:  0.228
CYP3A4-substrate:  0.209

ADMET: Excretion

Clearance (CL):  15.484
Half-life (T1/2):  0.134

ADMET: Toxicity

hERG Blockers:  0.005
Human Hepatotoxicity (H-HT):  0.919
Drug-inuced Liver Injury (DILI):  0.553
AMES Toxicity:  0.116
Rat Oral Acute Toxicity:  0.887
Maximum Recommended Daily Dose:  0.192
Skin Sensitization:  0.182
Carcinogencity:  0.361
Eye Corrosion:  0.003
Eye Irritation:  0.746
Respiratory Toxicity:  0.972

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC270899

Natural Product ID:  NPC270899
Common Name*:   Ferruginin A
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  MONLTQLSGPIJEC-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C30H36O4/c1-17(2)8-9-22-20(7)14-21-15-23-27(29(34)26(21)28(22)33)24(31)16-25(32)30(23,12-10-18(3)4)13-11-19(5)6/h8,10-11,14-16,32-34H,9,12-13H2,1-7H3
SMILES:  CC(=CCc1c(C)cc2cc3c(C(=O)C=C(C3(CC=C(C)C)CC=C(C)C)O)c(c2c1O)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL513685
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000018] Anthracenes

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO10596 Vismia sp. Species Hypericaceae Eukaryota n.a. n.a. n.a. PMID[12828475]
NPO25801 Harungana madagascariensis Species Hypericaceae Eukaryota stem bark n.a. n.a. PMID[16499321]
NPO25801 Harungana madagascariensis Species Hypericaceae Eukaryota Leaves n.a. n.a. PMID[17352491]
NPO25801 Harungana madagascariensis Species Hypericaceae Eukaryota n.a. n.a. n.a. PMID[26727375]
NPO25801 Harungana madagascariensis Species Hypericaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO10596 Vismia sp. Species Hypericaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO25801 Harungana madagascariensis Species Hypericaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT83 Cell Line MCF7 Homo sapiens GI50 = 5.0 ug.mL-1 PMID[512223]
NPT397 Cell Line NCI-H460 Homo sapiens GI50 = 3.3 ug.mL-1 PMID[512223]
NPT395 Cell Line SF-268 Homo sapiens GI50 = 4.9 ug.mL-1 PMID[512223]
NPT2 Others Unspecified Inhibition = 47.0 % PMID[512224]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC270899 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9922 High Similarity NPC249272
0.9921 High Similarity NPC114183
0.9844 High Similarity NPC12070
0.9769 High Similarity NPC53001
0.9695 High Similarity NPC87723
0.9248 High Similarity NPC191976
0.907 High Similarity NPC160499
0.9023 High Similarity NPC267205
0.8955 High Similarity NPC475088
0.8929 High Similarity NPC12402
0.8905 High Similarity NPC242994
0.8905 High Similarity NPC138099
0.8897 High Similarity NPC471905
0.8872 High Similarity NPC17083
0.8849 High Similarity NPC474961
0.8841 High Similarity NPC169452
0.8841 High Similarity NPC181560
0.8824 High Similarity NPC118919
0.8824 High Similarity NPC254847
0.8815 High Similarity NPC282780
0.8815 High Similarity NPC166480
0.8806 High Similarity NPC58685
0.8806 High Similarity NPC175738
0.8797 High Similarity NPC259942
0.8788 High Similarity NPC48248
0.8786 High Similarity NPC163948
0.8786 High Similarity NPC296752
0.8779 High Similarity NPC254492
0.8777 High Similarity NPC246638
0.8777 High Similarity NPC110810
0.8769 High Similarity NPC173978
0.8759 High Similarity NPC53206
0.8759 High Similarity NPC53414
0.875 High Similarity NPC283088
0.875 High Similarity NPC290803
0.8741 High Similarity NPC37299
0.8741 High Similarity NPC180261
0.8732 High Similarity NPC143685
0.8723 High Similarity NPC227841
0.8722 High Similarity NPC92624
0.8722 High Similarity NPC109123
0.8722 High Similarity NPC276238
0.8714 High Similarity NPC135524
0.8714 High Similarity NPC193555
0.8712 High Similarity NPC72667
0.8696 High Similarity NPC473622
0.8676 High Similarity NPC50924
0.8657 High Similarity NPC55949
0.8652 High Similarity NPC295712
0.8652 High Similarity NPC174905
0.8652 High Similarity NPC451542
0.8652 High Similarity NPC293545
0.8652 High Similarity NPC474203
0.8652 High Similarity NPC313047
0.8647 High Similarity NPC282923
0.8647 High Similarity NPC96024
0.8643 High Similarity NPC204045
0.8643 High Similarity NPC305845
0.8636 High Similarity NPC473691
0.8633 High Similarity NPC143438
0.8626 High Similarity NPC199273
0.8603 High Similarity NPC115458
0.8603 High Similarity NPC225051
0.8593 High Similarity NPC474517
0.8593 High Similarity NPC41847
0.8593 High Similarity NPC72669
0.8582 High Similarity NPC146647
0.8582 High Similarity NPC34414
0.8582 High Similarity NPC303910
0.8582 High Similarity NPC171460
0.8571 High Similarity NPC471530
0.8571 High Similarity NPC116513
0.8571 High Similarity NPC168471
0.8571 High Similarity NPC69424
0.8571 High Similarity NPC84672
0.8571 High Similarity NPC176130
0.8571 High Similarity NPC78364
0.8561 High Similarity NPC477454
0.8551 High Similarity NPC474311
0.8542 High Similarity NPC37709
0.8542 High Similarity NPC290194
0.8542 High Similarity NPC34802
0.854 High Similarity NPC287604
0.854 High Similarity NPC161964
0.854 High Similarity NPC472262
0.854 High Similarity NPC44437
0.8531 High Similarity NPC34482
0.8521 High Similarity NPC471682
0.8521 High Similarity NPC84266
0.8519 High Similarity NPC31799
0.85 High Similarity NPC190457
0.8496 Intermediate Similarity NPC328983
0.8496 Intermediate Similarity NPC3224
0.8496 Intermediate Similarity NPC267846
0.8489 Intermediate Similarity NPC245923
0.8489 Intermediate Similarity NPC62272
0.8485 Intermediate Similarity NPC142956
0.8485 Intermediate Similarity NPC236189
0.8478 Intermediate Similarity NPC161632
0.8472 Intermediate Similarity NPC271944
0.8472 Intermediate Similarity NPC110882
0.8472 Intermediate Similarity NPC85393
0.8472 Intermediate Similarity NPC470570
0.8467 Intermediate Similarity NPC48036
0.8467 Intermediate Similarity NPC314048
0.8462 Intermediate Similarity NPC193703
0.8462 Intermediate Similarity NPC244691
0.8462 Intermediate Similarity NPC10764
0.8462 Intermediate Similarity NPC471906
0.8462 Intermediate Similarity NPC21599
0.8462 Intermediate Similarity NPC48762
0.8456 Intermediate Similarity NPC244699
0.8456 Intermediate Similarity NPC205992
0.8451 Intermediate Similarity NPC182255
0.8451 Intermediate Similarity NPC257644
0.8451 Intermediate Similarity NPC94076
0.8451 Intermediate Similarity NPC19631
0.8451 Intermediate Similarity NPC239136
0.8444 Intermediate Similarity NPC474998
0.8444 Intermediate Similarity NPC99731
0.8444 Intermediate Similarity NPC278928
0.844 Intermediate Similarity NPC315578
0.8435 Intermediate Similarity NPC35
0.8433 Intermediate Similarity NPC162612
0.8433 Intermediate Similarity NPC23126
0.8433 Intermediate Similarity NPC72158
0.8433 Intermediate Similarity NPC316625
0.8433 Intermediate Similarity NPC169250
0.8433 Intermediate Similarity NPC105157
0.8433 Intermediate Similarity NPC103356
0.8433 Intermediate Similarity NPC100067
0.8433 Intermediate Similarity NPC30501
0.8433 Intermediate Similarity NPC98254
0.8433 Intermediate Similarity NPC190043
0.8433 Intermediate Similarity NPC329205
0.8433 Intermediate Similarity NPC266689
0.8429 Intermediate Similarity NPC13715
0.8429 Intermediate Similarity NPC230811
0.8429 Intermediate Similarity NPC4214
0.8425 Intermediate Similarity NPC158338
0.8425 Intermediate Similarity NPC100985
0.8425 Intermediate Similarity NPC97028
0.8425 Intermediate Similarity NPC288036
0.8425 Intermediate Similarity NPC329933
0.8425 Intermediate Similarity NPC65589
0.8425 Intermediate Similarity NPC97029
0.8421 Intermediate Similarity NPC103540
0.8417 Intermediate Similarity NPC315275
0.8417 Intermediate Similarity NPC155211
0.8417 Intermediate Similarity NPC474813
0.8417 Intermediate Similarity NPC272268
0.8417 Intermediate Similarity NPC472308
0.8406 Intermediate Similarity NPC474519
0.8403 Intermediate Similarity NPC471683
0.8397 Intermediate Similarity NPC154696
0.8394 Intermediate Similarity NPC70622
0.8382 Intermediate Similarity NPC62219
0.8382 Intermediate Similarity NPC108129
0.8382 Intermediate Similarity NPC17840
0.8382 Intermediate Similarity NPC247477
0.838 Intermediate Similarity NPC187843
0.838 Intermediate Similarity NPC290550
0.837 Intermediate Similarity NPC221777
0.837 Intermediate Similarity NPC473017
0.837 Intermediate Similarity NPC21305
0.8369 Intermediate Similarity NPC26924
0.8369 Intermediate Similarity NPC162939
0.8369 Intermediate Similarity NPC472903
0.8367 Intermediate Similarity NPC477914
0.8367 Intermediate Similarity NPC205766
0.8358 Intermediate Similarity NPC231774
0.8358 Intermediate Similarity NPC62952
0.8357 Intermediate Similarity NPC471452
0.8357 Intermediate Similarity NPC290030
0.8357 Intermediate Similarity NPC36868
0.8357 Intermediate Similarity NPC305060
0.8356 Intermediate Similarity NPC256672
0.8356 Intermediate Similarity NPC7025
0.8356 Intermediate Similarity NPC27221
0.8345 Intermediate Similarity NPC80035
0.8345 Intermediate Similarity NPC475917
0.8345 Intermediate Similarity NPC153088
0.8333 Intermediate Similarity NPC138472
0.8333 Intermediate Similarity NPC176208
0.8333 Intermediate Similarity NPC91105
0.8333 Intermediate Similarity NPC244351
0.8333 Intermediate Similarity NPC307174
0.8333 Intermediate Similarity NPC53896
0.8333 Intermediate Similarity NPC282577
0.8322 Intermediate Similarity NPC210942
0.8322 Intermediate Similarity NPC169990
0.8322 Intermediate Similarity NPC73061
0.8322 Intermediate Similarity NPC472211
0.8321 Intermediate Similarity NPC476847
0.8321 Intermediate Similarity NPC471851
0.8311 Intermediate Similarity NPC478148
0.8311 Intermediate Similarity NPC232645
0.8311 Intermediate Similarity NPC72958
0.8311 Intermediate Similarity NPC474417
0.8311 Intermediate Similarity NPC149526

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC270899 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8824 High Similarity NPD1509 Clinical (unspecified phase)
0.8723 High Similarity NPD7390 Discontinued
0.8538 High Similarity NPD1201 Approved
0.8489 Intermediate Similarity NPD5405 Approved
0.8489 Intermediate Similarity NPD5406 Approved
0.8489 Intermediate Similarity NPD5404 Approved
0.8489 Intermediate Similarity NPD5408 Approved
0.8421 Intermediate Similarity NPD1470 Approved
0.7905 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7872 Intermediate Similarity NPD943 Approved
0.7803 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7799 Intermediate Similarity NPD7473 Discontinued
0.7771 Intermediate Similarity NPD6959 Discontinued
0.7761 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7727 Intermediate Similarity NPD7819 Suspended
0.7724 Intermediate Similarity NPD6100 Approved
0.7724 Intermediate Similarity NPD6099 Approved
0.7722 Intermediate Similarity NPD6232 Discontinued
0.7704 Intermediate Similarity NPD2932 Approved
0.7671 Intermediate Similarity NPD2346 Discontinued
0.7667 Intermediate Similarity NPD2533 Approved
0.7667 Intermediate Similarity NPD2534 Approved
0.7667 Intermediate Similarity NPD2532 Approved
0.7667 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7651 Intermediate Similarity NPD3300 Phase 2
0.7639 Intermediate Similarity NPD6651 Approved
0.7639 Intermediate Similarity NPD1607 Approved
0.7626 Intermediate Similarity NPD1164 Approved
0.7582 Intermediate Similarity NPD3226 Approved
0.7574 Intermediate Similarity NPD3019 Approved
0.7568 Intermediate Similarity NPD2800 Approved
0.755 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7534 Intermediate Similarity NPD1510 Phase 2
0.7534 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7519 Intermediate Similarity NPD5951 Approved
0.7517 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD1240 Approved
0.75 Intermediate Similarity NPD7635 Approved
0.75 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7483 Intermediate Similarity NPD2935 Discontinued
0.7452 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7405 Intermediate Similarity NPD4750 Phase 3
0.7385 Intermediate Similarity NPD2342 Discontinued
0.7319 Intermediate Similarity NPD7163 Clinical (unspecified phase)
0.7315 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7315 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7308 Intermediate Similarity NPD4380 Phase 2
0.7297 Intermediate Similarity NPD3299 Clinical (unspecified phase)
0.7285 Intermediate Similarity NPD3750 Approved
0.7285 Intermediate Similarity NPD7003 Approved
0.7267 Intermediate Similarity NPD1549 Phase 2
0.7255 Intermediate Similarity NPD1511 Approved
0.725 Intermediate Similarity NPD7075 Discontinued
0.7235 Intermediate Similarity NPD8150 Discontinued
0.7215 Intermediate Similarity NPD1934 Approved
0.7203 Intermediate Similarity NPD2798 Approved
0.7197 Intermediate Similarity NPD6831 Clinical (unspecified phase)
0.7197 Intermediate Similarity NPD6599 Discontinued
0.7188 Intermediate Similarity NPD7768 Phase 2
0.7172 Intermediate Similarity NPD4625 Phase 3
0.717 Intermediate Similarity NPD2801 Approved
0.717 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7161 Intermediate Similarity NPD1512 Approved
0.7152 Intermediate Similarity NPD7411 Suspended
0.7143 Intermediate Similarity NPD3023 Approved
0.7143 Intermediate Similarity NPD3026 Approved
0.7143 Intermediate Similarity NPD3749 Approved
0.7134 Intermediate Similarity NPD7458 Discontinued
0.7134 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD2796 Approved
0.7125 Intermediate Similarity NPD8438 Clinical (unspecified phase)
0.7123 Intermediate Similarity NPD2313 Discontinued
0.7122 Intermediate Similarity NPD3025 Approved
0.7122 Intermediate Similarity NPD3024 Approved
0.7097 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD2344 Approved
0.7073 Intermediate Similarity NPD5711 Approved
0.7073 Intermediate Similarity NPD5710 Approved
0.7071 Intermediate Similarity NPD3412 Clinical (unspecified phase)
0.7068 Intermediate Similarity NPD9266 Approved
0.7068 Intermediate Similarity NPD74 Approved
0.7067 Intermediate Similarity NPD2799 Discontinued
0.7066 Intermediate Similarity NPD6020 Phase 2
0.7066 Intermediate Similarity NPD5844 Phase 1
0.7042 Intermediate Similarity NPD3972 Approved
0.7029 Intermediate Similarity NPD9493 Approved
0.702 Intermediate Similarity NPD1551 Phase 2
0.7007 Intermediate Similarity NPD3764 Approved
0.7 Intermediate Similarity NPD1651 Approved
0.6993 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6992 Remote Similarity NPD9267 Approved
0.6992 Remote Similarity NPD9263 Approved
0.6992 Remote Similarity NPD9264 Approved
0.6975 Remote Similarity NPD3882 Suspended
0.6971 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6966 Remote Similarity NPD6917 Clinical (unspecified phase)
0.6959 Remote Similarity NPD6663 Approved
0.6954 Remote Similarity NPD3748 Approved
0.6954 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6948 Remote Similarity NPD4628 Phase 3
0.6948 Remote Similarity NPD8166 Discontinued
0.6944 Remote Similarity NPD1283 Approved
0.6941 Remote Similarity NPD6559 Discontinued
0.6939 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6939 Remote Similarity NPD7008 Discontinued
0.6918 Remote Similarity NPD5736 Approved
0.6903 Remote Similarity NPD2309 Approved
0.6897 Remote Similarity NPD1203 Approved
0.6894 Remote Similarity NPD6801 Discontinued
0.6892 Remote Similarity NPD6410 Clinical (unspecified phase)
0.6892 Remote Similarity NPD3268 Approved
0.6886 Remote Similarity NPD6166 Phase 2
0.6886 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6886 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6883 Remote Similarity NPD1243 Approved
0.6875 Remote Similarity NPD1755 Approved
0.6864 Remote Similarity NPD7804 Clinical (unspecified phase)
0.686 Remote Similarity NPD8312 Approved
0.686 Remote Similarity NPD8313 Approved
0.6848 Remote Similarity NPD5494 Approved
0.6842 Remote Similarity NPD4308 Phase 3
0.6839 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6829 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6824 Remote Similarity NPD7074 Phase 3
0.6815 Remote Similarity NPD6799 Approved
0.681 Remote Similarity NPD3817 Phase 2
0.6806 Remote Similarity NPD4878 Approved
0.6806 Remote Similarity NPD9269 Phase 2
0.6805 Remote Similarity NPD7177 Discontinued
0.6798 Remote Similarity NPD6535 Approved
0.6798 Remote Similarity NPD6534 Approved
0.6786 Remote Similarity NPD7325 Clinical (unspecified phase)
0.6781 Remote Similarity NPD2797 Approved
0.6779 Remote Similarity NPD411 Approved
0.6778 Remote Similarity NPD7699 Phase 2
0.6778 Remote Similarity NPD7700 Phase 2
0.6765 Remote Similarity NPD7054 Approved
0.6763 Remote Similarity NPD9281 Approved
0.6761 Remote Similarity NPD9268 Approved
0.6759 Remote Similarity NPD4749 Approved
0.6757 Remote Similarity NPD6832 Phase 2
0.6753 Remote Similarity NPD1471 Phase 3
0.6748 Remote Similarity NPD1465 Phase 2
0.6744 Remote Similarity NPD844 Approved
0.6744 Remote Similarity NPD5031 Approved
0.6744 Remote Similarity NPD5027 Approved
0.6744 Remote Similarity NPD1809 Phase 2
0.6744 Remote Similarity NPD5029 Approved
0.6742 Remote Similarity NPD6213 Phase 3
0.6742 Remote Similarity NPD6212 Phase 3
0.6742 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6741 Remote Similarity NPD9265 Clinical (unspecified phase)
0.6736 Remote Similarity NPD1281 Approved
0.6725 Remote Similarity NPD7472 Approved
0.6715 Remote Similarity NPD4141 Clinical (unspecified phase)
0.6713 Remote Similarity NPD4626 Approved
0.6712 Remote Similarity NPD6696 Suspended
0.6706 Remote Similarity NPD3818 Discontinued
0.6705 Remote Similarity NPD4419 Clinical (unspecified phase)
0.6705 Remote Similarity NPD5028 Approved
0.6705 Remote Similarity NPD5034 Approved
0.6705 Remote Similarity NPD36 Approved
0.6705 Remote Similarity NPD4955 Approved
0.6705 Remote Similarity NPD4954 Approved
0.6705 Remote Similarity NPD5026 Approved
0.6692 Remote Similarity NPD1931 Clinical (unspecified phase)
0.6692 Remote Similarity NPD1930 Approved
0.6692 Remote Similarity NPD3495 Discontinued
0.6692 Remote Similarity NPD288 Approved
0.6692 Remote Similarity NPD1929 Approved
0.6692 Remote Similarity NPD9261 Approved
0.669 Remote Similarity NPD3091 Approved
0.669 Remote Similarity NPD1608 Approved
0.669 Remote Similarity NPD9717 Approved
0.6667 Remote Similarity NPD1609 Clinical (unspecified phase)
0.6667 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6667 Remote Similarity NPD3094 Phase 2
0.6667 Remote Similarity NPD289 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6648 Remote Similarity NPD5038 Approved
0.6648 Remote Similarity NPD5037 Approved
0.6647 Remote Similarity NPD7251 Discontinued
0.6647 Remote Similarity NPD5030 Phase 2
0.6646 Remote Similarity NPD7236 Approved
0.6645 Remote Similarity NPD230 Phase 1
0.6643 Remote Similarity NPD497 Approved
0.6625 Remote Similarity NPD6273 Approved
0.6624 Remote Similarity NPD3400 Discontinued
0.6621 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6621 Remote Similarity NPD3092 Approved
0.662 Remote Similarity NPD7610 Discontinued
0.6617 Remote Similarity NPD846 Approved
0.6617 Remote Similarity NPD940 Approved
0.6612 Remote Similarity NPD6781 Approved
0.6612 Remote Similarity NPD6780 Approved
0.6612 Remote Similarity NPD6778 Approved
0.6612 Remote Similarity NPD6776 Approved
0.6612 Remote Similarity NPD6782 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data